HFpEF vs. HFrEF: How To Improve Heart Failure Drug Development
XTalks
APRIL 15, 2021
Late-stage clinical trial failures are largely to blame for the lack of effective treatment options for patients with HFpEF, and poor five-year survival rates make this an area of great unmet need. Figure 1: The use of Mendelian randomization to validate genetic drug targets. Heart failure affects about 6.2
98 
Let's personalize your content